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Abstract
Background: Network-based approaches have recently gained considerable popularity in high- dimensional
regression settings. For example, the Cox regression model is widely used in expression analysis to predict the
survival of patients. However, as the number of genes becomes substantially larger than the number of samples,
the traditional Cox or L2-regularized Cox models are still prone to noise and produce unreliable estimations of
regression coefficients. A recent approach called the network-based Cox (Net-Cox) model attempts to resolve this
issue by incorporating prior gene network information into the Cox regression. The Net-Cox model has shown to
outperform the models that do not use this network information.
Results: In this study, we demonstrate an alternative network construction method for the outcome-guided gene
interaction network, and we investigate its utility in survival analysis using Net-Cox regression as compared with
conventional networks, such as co-expression or static networks obtained from the existing knowledgebase. Our
network edges consist of gene pairs that are significantly associated with the clinical outcome. We measure the
strength of this association using mutual information between the gene pair and the clinical outcome. We applied
this approach to ovarian cancer patients’ data in The Cancer Genome Atlas (TCGA) and compared the predictive
performance of the proposed approach with those that use other types of networks.
Conclusions: We found that the alternative outcome-guided mutual information network further improved the
prediction power of the network-based Cox regression. We expect that a modification of the network
regularization term in the Net-Cox model could further improve its prediction power because the properties of our
network edges are not optimally reflected in its current form.
Background
The Cox regression model [1] has been commonly used in
survival analysis to detect important features and to pre-
dict patient survival. Due to the advance of sequencing
technology, the number of genes or features in these ana-
lyses is becoming substantially larger than the number of
samples. Although several variant models, such as L1 −reg-
ularization [2] or L2 −regularization in Hilbert space [3],
have been proposed to resolve this issue, those variant
models are still prone to noise and over-fitting [4].
Recently, network-based approaches have gained consider-
able popularity for expression quantitative trait loci
(eQTL) studies and clinical outcome predictions in high-
dimensional regression settings. These approaches incor-
porate prior network information of either the features [5]
or outcomes [6], or both [7,8]. For survival analysis, Zhang
et al. [9] recently proposed a variant of the L2 −regularized
Cox model called the Net-Cox model, which is a network-
regularized Cox regression model. The typical types of
networks used in such approaches are either coexpression
networks, which are constructed by computing the corre-
lation between every pair of variables, or static networks,
such as the protein-protein interaction (PPI) network,
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which can be obtained from the existing knowledgebase.
In the Net-Cox model, co-expression and functional link-
age networks were incorporated in the survival analysis,
and the results showed enhanced performance when com-
pared with the conventional methods, which do not use
the network information.
A potential limitation of these conventional networks is
that the edges only reflect the information of within-
features or within-outcomes relations, and do not consider
the association between features and outcomes, which may
be useful in improving the predictive power. In this study,
we show that the outcome-guided mutual information net-
work improves the performance of survival analysis in the
Net-Cox regression [9]. We demonstrate the utility of this
outcome-guided gene network with the analysis of a TCGA
ovarian cancer dataset and compare its performance with
those of survival analyses that use other types of networks.
Methods
Background on survival analysis using Cox regression
First, we describe the basic formulation of Cox regression
[1] for survival analysis using expression and survival data.
Given a gene expression profile X, which consists of n
patients and p genes, the risk of an event at time t for the
ith patient with gene expression Xi = (Xi1 ,...,Xip)′ is
defined as h (t|Xi) = h0(t)eX′ iβ, where b = (b1,...,bp)′ is a
regression coefficient vector, and h0(t) denotes the baseline
hazard function at t. The coefficient b and the function h0
are generally unknown and need to be estimated. In a tra-
ditional Cox regression model, the estimation of b is based














Here, δi is the observed status (δi = 1 implies
observed; δi = 0 implies censored), ti represents the
event time of the ith patient, and R(ti) is the subset of
patients who survived to time ti. Once the coefficient
vector βˆ is obtained, a Breslow estimator can estimate






Regularized Cox regression in high-dimensional setting
When p ≫ 1, the Cox regression model is prone to noise
and tends to produce unreliable estimations of regression
coefficients. Several solutions that shrink the coefficients
have been proposed. A common solution is the L2 −Cox
model, which uses the penalized total log-likelihood:




















β2j is the regularization term and l con-
trols the amount of shrinkage. Net-Cox regression is an
extension of the L2 −Cox model and uses the following
penalized log-likelihood:














in which lb′Γb is the penalty term and Γ = (1 - a) L
+ aI conveys prior network information between genes.
Here, L = I − S, where I is the identity matrix and S is a
normalized Laplacian matrix, which comes from the
gene network.
The parameter a ∈ (0,1] controls the contribution of
network information to the model. When a is small,
more network information is incorporated into the pen-
alty term than when a is large. We note that when a = 1,
the network-based cox regression model reduces to the
L2 −Cox model that does not use any network
information.
The typical network used for this type of network-
based approach is the coexpression network, in which
the edge weights correspond to the correlation between
expression vectors of two genes [6]. In [9], a functional
linkage network was constructed from the existing
knowledgebase. We note that both types of networks do
not reflect information about the relation between the
features and the outcomes inferred from a given dataset.
Therefore, we consider an alternative approach of con-
structing and utilizing outcome-guided mutual informa-
tion network in survival analysis. The detailed procedures
are explained in the following sections.
Gene interaction networks associated with clinical
outcome
Mutual information is an information-theoretic measure
that reveals the dependency or association between two
random variables [10] and is defined as follows:
I(X;Y) = H(X) + H(Y) − H(X,Y),
where H(X) and H(Y) denote the entropies of the respec-
tive variables, X and Y, and H(X, Y) denotes the joint
entropy of X and Y. It can be used to detect both linear
and nonlinear relations between two random variables
[11]. While many previous studies generally used mutual
information to detect dependency between two features of
the same type, more recent approaches in [12,13] have
also extended the mutual information to assess the asso-
ciation between expressions of two genomic features, X1
and X2, and the clinical outcome Y as follows:
I(X1,X2;Y) = H(X1,X2) + H(Y) − H(X1,X2,Y).
Note that genomic feature values, such as gene
expressions or clinical outcome values, are often
Jeong et al. BMC Systems Biology 2015, 9(Suppl 1):S8
http://www.biomedcentral.com/qc/1752-0509/9/S1/S8
Page 2 of 12
numeric. To compute the mutual information, we dis-
cretize the genomic feature values using a histogram-
based technique as in [14]. In the case of survival data, a
simple thresholding scheme converts the outcome vari-
able of the survival month to a binary variable. In the
case of the TCGA dataset used in this study, we split
the patients into short-term living (≤ 3 years) and long-
term living (> 3 years). Patients who are reported as liv-
ing and have an overall survival time less than 3 years
are filtered out of this study.
Computation of mutual information for every pair of
genes and the clinical outcome variable produce a com-
plete network between genes. We can further filter out
less significant edges by using the permutation testing
scheme proposed in [14]. Through the repeated permuta-
tion of clinical outcome labels and the re-computation of
mutual information values, a threshold θ is defined as the
maximum of the average mutual information values for
each gene pair. This θ can be used as a base threshold to
remove insignificant edges. However, this threshold still
leaves a large number of edges that may not be fully ben-
eficial to the downstream analysis. In this study, another
parameter s, which amplifies the significance level by a
factor of (1 + s), was proposed to create a stricter cut-off.
In particular, the filtered mutual information network





gi, gj ∈ P and I
(
gi, gj;Y
) ≥ θ(1 + σ )} ,
where P is the set of all genes, Y denotes the binary
survival status of patients, and I(gi, gj; Y) is the mutual
information of the gene pair (gi, gj ) and Y. We adopt
this thresholding scheme and test the performance of
different parameter values. In order to apply the net-
work to the Net-Cox model, we also normalize Gs and







Gσij and Cii =
∑
j
G′σij both of which are
diagonal matrices.
Dataset
We use genomic profiles and clinical outcome data from
patients with ovarian serous cystadenocarcinoma in
TCGA. Genomic profiles of copy number alterations
(CNAs), messenger RNA (mRNA), and methylation
(METH) are used in the experiments. We remove genes
or patients with missing values and extract genes that are
common to all three profiles. As a result, our data matrix
consists of expressions and alterations of 10,022 genes and
340 patients for each of the three profiles.
Evaluation measure
We compare the performance of the Net-Cox model
using the proposed mutual information networks with
those of models using a gene co-expression and gene
functional linkage network as seen in [9]. In order to
create a baseline, an analysis of the L2 − Cox model,
which does not use any network information, is per-
formed. This is the same as setting a = 1 in the Net-
Cox model.
With each run of the Net-Cox analysis, the prognostic
indices PI = X′βˆ are calculated as prediction markers,
where X is the test data not used in training, and the
regression coefficient βˆ is estimated from given training
data, network information, and the parameters. We eval-
uate the prediction performance using a time-dependent
area under the curve (AUC) [15].
Specifically, time-dependent sensitivity and specificity
functions are defined as follows:
sensitivity[c, t|f (X)] = Pr{f (X) > c|δ(t) = 1},
specificity[c, t|f (X)] = Pr{f (X) > c|δ(t) = 0},
in which c is the cut-off point, t is the survival time,
f(X) are the prognostic indices, f (X) = X′β and δ(t) is
the event indicator at time t [16]. Upon examination of
sensitivity[c, t|f(X)] and 1 - specificity[c, t|f(X)], we can
define ROC[t|f(X)] as receiving operating characteristic
(ROC) curves at any time t and AUC[t|f (X) ] as the
area under the ROC curves at any time t. The larger
AUC[t|f(X)] is, the better our prediction model performs
at time t.
In addition, we evaluate the performance, using a vali-
dation set and the log-rank test [17], to analyze whether
the patients are properly classified: high-risk or low-risk.
We rank patients in descending order by their prognos-
tic indices (PI) and divide them into a high-risk group
containing the top 40% of patients and a low-risk group
containing the bottom 40%. We then test the validity of
this group assignment by using the log-rank test and the
true survival information.
Cross validation
We select the optimal parameters, l and a, that respec-
tively control the degree of sparsity and the amount of
network constraint in the Net-Cox model using a 5-fold
cross validation process. We reserve 20% of all the sam-
ples in this study for validation (the validation set) and
use the remaining 80% (the training set) for cross valida-
tion in order to optimize the parameters and check the
cross-validation error. In the case of mutual information
networks, we also choose the optimal s using cross-vali-
dation. The average time-dependent AUC is used as an
evaluation measure for each genomic profile and the dif-
ferent kinds of networks.
We trained each model five times using a 5-fold cross
validation process on the training set. At each run, we
estimate the regression coefficient βˆ and the mutual
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information network (or co-expression network) on four
folds of the training data. The estimated coefficient βˆ
and the remaining fold, consisting of 20% of the training
data, are then used to calculate the prognostic indices
PI = X′b, which are, in turn, used to rank the patients
according to their expected survival time, or month.
To examine how the mutual information network fil-
tered by significance level s contributes to the perfor-
mance of the Net-Cox model, we experiment with the
complete mutual information network and those networks
filtered by s, where s = [0, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3]
for each profile. This corresponds to eight mutual infor-
mation networks on each profile, including the complete
network. We vary the parameters l = [10−4,10−3, 10−2,
10−1] and a = [0.1, 0.3, 0.5, 0.7, 0.9, 1]. As a result, we
choose the optimal (l, a) pair with the best performance,
in terms of the time-dependent ROC curves, for each net-
work and each profile.
Enrichment analysis
In order to assess the biological significance of the
results, we performed a gene list enrichment analysis for
the 100 genes with the largest regression coefficients for
each profile using ToppGene http://toppgene.cchmc.org
[18]. The enrichment analysis is based on Gene Ontology
[19] and Pathway and Disease [20]. The terms that have
adjusted p-values under 0.05 when using the Benjamini-
Hochberg correction [21] are considered biologically sig-
nificant. We also ran the enrichment test on the genes in
the network consisting of the 100 edges with the largest
mutual information values for each profile.
Results and discussion
Optimal parameter selection using cross validation
We first examined the performance behavior of the
mutual information network based Net-Cox model as a
function of the parameter s (Figure 1). Note that as the
value of s increases, fewer edges remain in the network.
In Figure 1, the leftmost x-tick label “comp” represents the
result obtained using the complete network, and the fol-
lowing x-ticks correspond to different s values. Overall,
the best performance resulted not from the complete net-
work but from the network filtered by s. Therefore, redu-
cing less significant information and using only significant
edges seem to improve the performance of the network-
regularized regression model. When the CNA and methy-
lation profiles were examined, the best result was obtained
using the largest test value of s = 0.3, for which 9,896 and
6,011 edges, respectively, remained, which was about
0.01% of the total number of pairs. In contrast, the mRNA
profile preferred a larger network consisting of 568,486
edges (about 1%) with the optimum at s = 0.1.
We also optimized the parameters l and a using a
5-fold cross validation process (Table 1). We found that
the optimal a value for the mutual information network
was smaller than those of the co-expression and func-
tional linkage networks. This implies that the mutual
information network contributed more to the regression
Figure 1 Prediction accuracy of the mutual information network-based Net-Cox model as a function of the network significance
parameter s. Average time-dependent AUC using 5-fold cross validation on training data is shown across s.
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Table 1 Optimal parameters and averaged time-dependent AUCs of each network using 5-fold cross validation on
training data
Profile Network s l a Mean (time AUC)
CNA Mutual Information 0.30 10−3 0.1 0.5875
Correlation - 10−3 0.9 0.5817
Functional Linkage - 10−3 0.3 0.5786
L2 − Cox - 10
−3 1.0 0.5810
mRNA Mutual Information 0.10 10−4 0.1 0.6317
Correlation - 10−4 0.9 0.6280
Functional Linkage - 10−4 0.3 0.6242
L2 − Cox - 10
−4 1.0 0.6288
METH Mutual Information 0.30 10−4 0.5 0.5912
Correlation - 10−4 0.7 0.5894
Functional Linkage - 10−4 0.3 0.5860
L2 − Cox - 10
−4 1.0 0.5899
Figure 2 Performance comparison of different network types in terms of 5-fold cross-validation accuracy.
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model than the other approaches. Moreover, the average
time-dependent AUC was highest when the mutual
information based network was used in all profiles.
However, we also note that the median time-dependent
AUC was not always highest for the mutual information
network, which may imply complementary properties of
different types of networks. In Figure 2, the bar plot for
the average time-dependent AUC and the boxplot for
the distribution of the time-dependent AUC across all
the time points and the 5-fold experiments are shown.
Performance comparison on validation set
After selection of the best parameters for each network,
we re-trained each model using the entire training set
and then applied the obtained regression model to the
holdout validation set. Figure 3 shows a comparison
between the resulting time-dependent AUCs. The
mutual information based network had the best perfor-
mance for the mRNA profile and comparable results for
the other profiles. Figure 4 shows the Kaplan-Meier sur-
vival curves and p-values from the log-rank tests with
respect to the patient group assignment for each
approach. Examining the CNA and mRNA profiles,
every method revealed significant results (p-value <
0.05) with the log-rank test, except for the functional
linkage network on the CNA profile. However, all the
methods showed insignificant results for the methylation
profile. It appears that the interaction effect in the
Figure 3 Performance comparison of different network types on validation set.
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methylation profile is substantially less than in other
profiles.
Signature genes for each profile
In order to examine the genes that have the strongest
marginal association with survival, we displayed the five
largest regression coefficients in each profile as a heat-
map (Figure 5). The top five genes from each profile
were all distinct with no overlap, but some genes had
large coefficients in multiple profiles. The top genes from
the CNA profile had smaller overall regression coeffi-
cients than the top genes in other profiles. Moreover, the
top genes in the CNA profile had larger regression coeffi-
cients than those in other profiles, which suggests that
the roles of these genes are more prominent in other
genomic levels.
We find that the identified genes are associated with
ovarian cancer in many previous studies. The gene with
the largest coefficient in the CNA profile was URI1, prefol-
din-like chaperone (URI1), which is reported to be an
Figure 4 Kaplan-Meier survival curves (high-risk group: red line; low risk group: blue line) and log-rank test results on validation set
for each profile and network (A–Mutual information based network; B–Correlation network; C–Functional linkage network; D–L2 -Cox).
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Figure 5 Heat-map for the regression coefficients of 15 selected genes. The five genes having the largest regression coefficients are
selected for each profile and merged together.
Table 2 Significantly enriched terms (using ToppGene) in the 100 genes that have the largest regression coefficients
for each profile
Profile Category ID Name p-value Adjusted p-value Count Total
CNA GO:BP GO:0048706 embryonic skeletal system development 5.99E-06 1.25E-02 7 129
GO:BP GO:0048704 embryonic skeletal system morphogenesis 1.43E-05 1.50E-02 6 98
GO:BP GO:0009952 anterior/posterior pattern specification 2.17E-05 1.52E-02 8 217
Disease ctd:D010051 Ovarian Neoplasms 5.24E-04 2.84E-02 4 78
Disease ctd:D002277 Carcinoma 7.42E-03 3.66E-02 4 161
GO:BP GO:0031442 positive regulation of mRNA 3’-end processing 7.94E-05 4.15E-02 3 16
GO:BP GO:0031440 regulation of mRNA 3’-end processing 1.15E-04 4.80E-02 3 18
mRNA GO:MF GO:0004568 chitinase activity 4.80E-06 1.78E-03 3 7
GO:BP GO:0006032 chitin catabolic process 4.83E-06 4.94E-03 3 7
GO:BP GO:0006030 chitin metabolic process 4.83E-06 4.94E-03 3 7
GO:BP GO:1901072 glucosamine-containing compound catabolic process 7.70E-06 5.24E-03 3 8
GO:MF GO:0086080 protein binding involved in heterotypic cell-cell adhesion 8.12E-05 1.50E-02 2 3
GO:MF GO:0098631 protein binding involved in cell adhesion 1.62E-04 1.50E-02 2 4
GO:MF GO:0098632 protein binding involved in cell-cell adhesion 1.62E-04 1.50E-02 2 4
GO:BP GO:0046348 amino sugar catabolic process 3.86E-05 1.97E-02 3 13
GO:MF GO:0008061 chitin binding 2.69E-04 1.99E-02 2 5
GO:MF GO:0030492 hemoglobin binding 7.45E-04 4.61E-02 2 8
METH GO:CC GO:0030424 axon 9.91E-06 1.95E-03 11 409
GO:CC GO:0043025 neuronal cell body 2.06E-04 1.57E-02 10 478
GO:CC GO:0043195 terminal bouton 3.15E-04 1.57E-02 4 62
GO:CC GO:0036477 somatodendritic compartment 3.19E-04 1.57E-02 12 705
GO:CC GO:0043005 neuron projection 4.07E-04 1.61E-02 14 945
GO:CC GO:0044297 cell body 5.10E-04 1.68E-02 10 536
GO:CC GO:0032983 kainate selective glutamate receptor complex 7.48E-04 2.11E-02 2 8
GO:MF GO:0004952 dopamine neurotransmitter receptor activity 2.80E-04 4.01E-02 2 5
GO:MF GO:0001965 G-protein alpha-subunit binding 3.95E-04 4.01E-02 3 27
GO:MF GO:0015075 ion transmembrane transporter activity 4.14E-04 4.01E-02 13 819
GO:MF GO:0022857 transmembrane transporter activity 5.21E-04 4.01E-02 14 951
GO:MF GO:0015026 coreceptor activity 5.98E-04 4.01E-02 3 31
GO:MF GO:0022891 substrate-specific transmembrane transporter activity 7.68E-04 4.29E-02 13 875
GO:MF GO:0022892 substrate-specific transporter activity 9.57E-04 4.58E-02 14 1012
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oncogene that amplified in ovarian cancer cells [22]. Dual-
Specificity Tyrosine-(Y)-Phosphorylation Regulated Kinase
1B (DYRK1B), which is over-expressed in a wide spectrum
of ovarian cancer cell lines and human specimens [23],
was the fourth highest gene. The largest coefficient gene
from the mRNA profile, Oviductal Glycoprotein 1
(OVGP1), is reported to be a more accreted detection
marker than other markers of ovarian epithelial cancers
Figure 6 Gene-gene interaction sub-network constructed by using the 100 edges with the largest mutual information values on each
profile (A: CNA, B: mRNA, C: METH).
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[24]. Over-expression of the Elafin/Peptidase Inhibitor 3
(PI3) gene from the mRNA profile is associated with poor
overall survival [25]. We found no reported associations of
the top five genes in the methylation profile with ovarian
cancer from previous studies.
An enrichment analysis was performed for the 100
genes having the largest coefficients in each profile
(Table 2). Many significantly enriched terms demon-
strated an association with ovarian cancer. For example,
the genes URI1, Processing Of Precursor 4 (POP4), Pleck-
strin Homology Domain Containing, Family F Member 1
(PLEKHF1), and DYRK1B from the CNA profile were
enriched in the Ovarian Neoplasms term (ctd:D010051)
of Disease. For Gene Ontology, the top 100 genes in the
CNA profile were primarily enriched in the Biological
Process (BP) terms. The Hox family of homeobox genes
was enriched in the terms related with the embryonic
skeletal system (GO:0048706; GO:0048704), and these
genes are critical for cell migration and DNA repair
[26]. The genes in the mRNA profile that were enriched
in the Chitinases-related terms were already known for
their cancer indication roles [27]. Therefore, we can
conclude that the genes with large regression coeffi-
cients are expected to be related to ovarian cancer.
Network analysis
To illustrate the general topology of the mutual informa-
tion network and its effect on prediction performances
more closely, we constructed gene interaction sub-net-
works by using the 100 edges with the largest mutual
information values for each profile (Figure 6). The color
of each node represents the strength of its marginal
effect. We also see many genes with weak marginal
effects appear in the network. Topologies of the networks
were analyzed by Cytoscape [28] and summarized in
Table 3. The three networks reveal different network
structures and topologies. The CNA network consists of
a smaller number of connected components than the
others (7 versus 54 and 50). It also shows a denser con-
nection between the genes. The network centralization
value is about five times higher, and its average number
of neighbors is about twice as much. In addition, the
overall coefficients of the genes in the CNA network
were smaller than those in the other profiles. Considering
that those genes have high mutual information values
and, hence, strong interactive effects, this may imply that
the interaction effect on survival in the CNA profile is
more dominant than the marginal effect with each gene.
The R2 value for the power-law distribution of the
mRNA and methylation networks were 0.922 and 0.909,
respectively, which shows strong scale freeness [29], as is
the case with many other biological networks [30-33].
Table 4 summarizes the enrichment test results for
the genes in each sub-network. The network from the
methylation profile was mainly enriched in GO Mole-
cular Function (MF) terms. Networks for the CNA and
mRNA profiles were not enriched in GO terms but in
terms of diseases related to ovarian cancer, such as
Neoplasms (ctd:D009369), Carcinoma (ctd:D002277),
and Neoplasm Recurrence, Local (ctd:D009364).
Further, the CNA profile network was enriched in
other related disease terms, such as Obesity (ctd:
D009756) and BMI (Body Mass Index) [34], and
Table 3 Network properties of mutual information sub-
network for each profile
Properties CNA mRNA METH
Nodes 78 154 149
Connected components 7 54 50
Network centralization 0.312 0.058 0.052
Characteristic path length 2.117 2.187 2.164
Average number of neighbors 2.564 1.299 1.342
Network density 0.033 0.008 0.009
Network heterogeneity 1.383 0.828 0.809
R2 of node degree distribution 0.672 0.922 0.909
Table 4 Significantly enriched terms (using ToppGene) in the sub-network consisting of the gene pairs that have the
100 largest mutual information values
Profile Category ID Name p-value Adjusted p-value Count Total
CNA Disease ctd:D006949 Hyperlipidemias 1.76E-05 2.24E-03 3 13
Disease ctd:D009765 Obesity 1.98E-03 1.21E-02 4 132
Disease ctd:D007333 Insulin Resistance 8.96E-03 2.42E-02 2 35
Disease ctd:D009369 Neoplasms 1.05E-02 2.78E-02 2 38
mRNA Disease ctd:D002277 Carcinoma 1.19E-04 1.23E-02 8 161
Disease ctd:D009364 Neoplasm Recurrence, Local 1.25E-02 4.96E-02 3 52
METH GO:MF GO:0008528 G-protein coupled peptide receptor activity 4.15E-05 1.21E-02 7 120
GO:MF GO:0001653 peptide receptor activity 4.86E-05 1.21E-02 7 123
GO:MF GO:0004942 anaphylatoxin receptor activity 1.78E-04 1.78E-02 2 3
GO:MF GO:0004948 calcitonin receptor activity 1.78E-04 1.78E-02 2 3
GO:MF GO:0004800 thyroxine 5’-deiodinase activity 1.78E-04 1.78E-02 2 3
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Insulin Resistance (ctd:D007333) [35] and Hyperlipi-
daemia (ctd:D006949) [36].
Conclusions
In this study, we investigated the utility of an alternative
network construction approach based on mutual infor-
mation in network-based Cox regression. Our results
show that the mutual information based network can
further improve prediction performance in survival ana-
lyses. Moreover, the permutation testing scheme used to
discard insignificant pairs improved the prediction
performance.
Overall, the performance gain of this alternative
approach over existing methods was rather marginal. It
seems due to a mismatch between the high mutual
information value and the small value of the penalty
term (ψ(β)) = 12
∑p
i,j
Si,j(βi − βj)2) in the Net-Cox
model–it does not necessarily mean that the gene pairs
containing high mutual information with respect to
survival should have similar marginal effects because
the mutual information measure is more concerned
with the interaction effect. Even with this discrepancy,
results based on the mutual information network are
still promising. In future studies, the regularization
term could be modified to better reflect the informa-
tion contained in the mutual information network and,
hence, further improve the performance. Another
direction would be to apply this network scheme to
network-based approaches in other domains.
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